A research team led by Dr. Beatrice Nardone, research assistant professor of dermatology at Northwestern University Feinberg School of Medicine, discovered that daily consumption of aspirin could significantly increase the risk for melanoma (skin cancer) in men, compared to women.
A multicentre, double-blind, randomized, controlled clinical trial of patients who underwent total hip or knee replacement surgery showed that aspirin was as effective as rivaroxaban, the standard anti-coagulation medication, at preventing post-operative venous thromboembolism (VTE).
Adding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment, new research has shown.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.